isotretinoin

Acne Vulgaris Treatment Update
acne vulgaris
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Hilary Baldwin, a board-certified dermatologist and medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY. With the heavy acne tool box these days, how do you pick which medications to use? …

Continue reading "Acne Vulgaris Treatment Update"

JDD April 2023 Issue Highlights
by NEXT STEPS IN DERM TEAM on
The April issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, features, and case reports,  with topics ranging from hormonal therapy in hidradenitis suppurativa, private equity in dermatology, vitiligo and its associated comorbidities, novel topical products for facial dyschromia, and many more.  Check out this month’s issue highlights straight …

Continue reading "JDD April 2023 Issue Highlights"

Skincare Mondays | Regrounding on Retinoids
retinoids
by Johnson & Johnson Consumer Health on
Retinoids Retinoids are a class of molecules derived from vitamin A or having structural and/or functional similarities to vitamin A.1 The first medicinal use of vitamin A dates back to ancient Egypt where liver juices were used to treat endemic night blindness.2 Prescribed topical retinoids are divided into 6 classes: Tretinoin (all-trans retinoic acid), adapalene, tazarotene, trifarotene, al …

Continue reading "Skincare Mondays | Regrounding on Retinoids"

Key Tips for Dermatologists in Prescribing and Managing JAK Inhibitors
JAK Inhibitors
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Neal Bhatia (a board-certified Dermatologist who serves as Director of Clinical Dermatology at Therapeutics Clinical Research ) about the latest with JAK inhibitors. Watch as he summarizes the most recent trials, approvals, and developments. Plus why doctors shouldn't be afraid to dive in w …

Continue reading "Key Tips for Dermatologists in Prescribing and Managing JAK Inhibitors"

JDD Issue Highlights | June 2022: Acne & Rosacea
acne
by NEXT STEPS IN DERM TEAM on
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP …

Continue reading "JDD Issue Highlights | June 2022: Acne & Rosacea"